The Effect of Subchronic Administration of 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1- -1H-pyrrolo[2,3-d]pyridazine (CS-526), a Novel Acid Pump Antagonist, on Gastric Acid Secretion and Gastrin Levels in Rats